HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preventive Potential of Resveratrol in Carcinogen-Induced Rat Thyroid Tumorigenesis.

Abstract
Thyroid cancer (TC) is the most common endocrine malignancy without reliable preventive agent. Resveratrol possesses in vitro anti-TC activities; while its effect(s) on thyroid tumorigenesis remains unknown. This study aims to address this issue using DEN/MNU/DHPN-induced rat carcinogenesis model. 50 male Sprague-Dawley rats were separated into four groups as Group-1 (5 rats); normally fed; Group-2 (15 rats); DEN/MNU/DHPN treatment only; Group-3 (15 rats) and -4 (15 rats); DEN/MNU/DHPN treatment; followed by resveratrol intragastric (IG) injection and intraperitoneal (IP) injection; respectively; in two-day intervals for 30 weeks. The results revealed that the average resveratrol concentration in thyroid tissues was 1.278 ± 0.419 nmol/g in IG group and 1.752 ± 0.398 nmol/g in IP group. The final body weights of Group-3 and Group-4 were lighter than that (p > 0.05) of Group-1; but heavier than Group-2 (p < 0.05). TC-related lesions (hyperplasia and adenomas) were found in 53.3% of Group-2; 33.3% Group-3 and 26.7% Group-4. Lower serum carcino-embryonic antigen (CEA) and thyroglobulin (Tg) levels; down-regulated expression of IL-6 and cyclooxygenase-2 (COX-2); reduction of NF-κB/p65 nuclear translocation; and elevated IkBα expression were found in the thyroid tissues of Group-3 and Group-4 in comparison with that of Group-2. These results demonstrate that IG and IP administered resveratrol efficiently reduces the frequency and severity of DEN/MNU/DHPN-caused TC-related lesions and would be of values in thyroid tumor prevention.
AuthorsXu Zheng, Bin Jia, Xue Song, Qing-You Kong, Mo-Li Wu, Ze-Wen Qiu, Hong Li, Jia Liu
JournalNutrients (Nutrients) Vol. 10 Issue 3 (Feb 28 2018) ISSN: 2072-6643 [Electronic] Switzerland
PMID29495605 (Publication Type: Journal Article)
Chemical References
  • Anticarcinogenic Agents
  • Carcinoembryonic Antigen
  • Interleukin-6
  • Nfkbia protein, rat
  • Nitrosamines
  • Rela protein, rat
  • Stilbenes
  • Transcription Factor RelA
  • NF-KappaB Inhibitor alpha
  • Diethylnitrosamine
  • diisopropanolnitrosamine
  • Methylnitrosourea
  • Thyroglobulin
  • Cyclooxygenase 2
  • Ptgs2 protein, rat
  • Resveratrol
Topics
  • Adenoma (blood, chemically induced, pathology, prevention & control)
  • Animals
  • Anticarcinogenic Agents (pharmacology)
  • Carcinoembryonic Antigen (blood)
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic (chemically induced, drug effects, metabolism, pathology)
  • Cyclooxygenase 2 (metabolism)
  • Diethylnitrosamine
  • Humans
  • Hyperplasia
  • Interleukin-6 (metabolism)
  • Male
  • Methylnitrosourea
  • NF-KappaB Inhibitor alpha (metabolism)
  • Nitrosamines
  • Rats, Sprague-Dawley
  • Resveratrol
  • Stilbenes (pharmacology)
  • Thyroglobulin (blood)
  • Thyroid Gland (drug effects, metabolism, pathology)
  • Thyroid Neoplasms (blood, chemically induced, pathology, prevention & control)
  • Time Factors
  • Transcription Factor RelA (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: